15:15-16:00, 27 SeptemberBayside BallroomSession 1: Keynote Address: Helgi Ingolfur Ingolfsson, PhD, Livermore National Laboratory, CaliforniaHelgi Ingolfur Ingolfsson, PhDComputational Biologist, Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, California“Machine Learning, Multiscale …
Online Program Click Here
By Thomas Henry, CIRI-Centre International de Recherche en InfectiologieAlain Charbit was trained in bacterial genetics in France. He obtained his PhD in Microbiology in 1984 and joined the CNRS in 1991.Early …
Online Abstract Submission Form Abstract Submission Deadline: 11 May 2026 00Days 00Hours 00Minutes 00Seconds Tularemia 2026, scheduled for 27-30 September at the Portofino Hotel & Marina in Redondo Beach, California, will focus …
https://mailchi.mp/bc5ead4853be/seeking-your-input-attendance-at-tularemia-2026-september-27-30-in-southern-california-13905088
Various Session Photos Gala Dinner at the O2 Restaurant, Thursday, September 28th
Login to Online Membership System Please use the new online membership system to renew your commitment to Tularemia research and join or renew TULISOC dues today!The new online membership system …
Funding for this conference is made possible, in part, by the Food and Drug Administration. This event is not a FDA sponsored event. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government.
This award is subject to the programmatic Terms and Conditions as specified in the Funding Opportunity Announcement: PAR 19-306 entitled FDA Scientific Conference Grant Program (R13).
Tularemia is a rapidly progressive and potentially fatal zoonosis of humans caused by the intracellular bacterial pathogen, Francisella tularensis. Because of its low infectious dose and lethality when inhaled, F. tularensis was developed as a bioweapon by three countries, and remains a potential bioterroist agent. Research and understanding of tularemia pathogenesis, diagnosis, treatment, and prevention have been significantly advanced by the International Conferences on Tularemia, the first of which was held in Umea, Sweden in 1995. Attendance and impact of this triennial series of meetings has grown steadily in subsequent years. At present, this conference is a unique venue that brings together scientists and interested parties from the U.S., Canada, Scandinavia, Europe, Russia, and Japan.
